Prenatal diethylstilbestrol exposure and risk of breast cancer

Cancer Epidemiology Biomarkers and Prevention

Volumn 15, Issue 8, 2006, Pages 1509-1514

  Palmer, Julie R ^a   Wise, Lauren A ^a   Hatch, Elizabeth E ^b   Troisi, Rebecca ^c   Titus Ernstoff, Linda ^d   Strohsnitter, William ^e   Kaufman, Raymond ^f   Herbst, Arthur L ^g   Noller, Kenneth L ^e   Hyer, Marianne ^h   Hoover, Robert N ^c  

^a BOSTON UNIVERSITY   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

^d NORRIS COTTON CANCER CENTER   (United States)

^e TUFTS MEDICAL CENTER   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g UNIVERSITY OF CHICAGO   (United States)

^h INFORMATION MANAGEMENT SERVICES INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLSTILBESTROL;

ADULT; ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER RISK; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; PARITY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; QUESTIONNAIRE; SELF REPORT; STATISTICAL SIGNIFICANCE;

ADULT; BREAST NEOPLASMS; CARCINOGENS; COHORT STUDIES; DIETHYLSTILBESTROL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MIDDLE AGED; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; QUESTIONNAIRES; RISK FACTORS;

EID: 33748064976     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-06-0109     Document Type: Article

References (37)

1. Trichopoulos D, Lipman R. Mammary gland mass and breast cancer risk. Epidemiology 1992;3:523-6.
2. Trichopoulos D, Lagiou P, Adami H-O. The crucial role of the number of mammary tissue-specific stem cells. Breast Cancer Res 2005;7:13-7.
3. Sanderson M, Williams M, Malone K, et al. Perinatal factors and risk of breast cancer. Epidemiology 1996;7:34-7.
4. Michels KB, Trichopoulos D, Robins JM, et al. Birth weight as a risk factor for breast cancer. Lancet 1996;348:1542-6.
5. Vatten LJ, Maehle BO, Lund Nilsen TI, et al. Birth weight as a predictor of breast cancer: a case-control study in Norway. Br J Cancer 2002;86:89-91.
6. Ahlgren M, Sorensen T, Wohlfahrt J, et al. Birth weight and risk of breast cancer in a cohort of 106,504 women. Int J Cancer 2003;107:997-1000.
7. Innes K, Byers T, Schymura M. Birth characteristics and risk for breast cancer in very young women. Am J Epidemiol 2000;52:1121-8.
8. Ekbom A, Hsieh CC, Lipworth L, Adami HO, Trichopoulos D. Intrauterine environment and breast cancer risk in women: a population-based study. J Natl Cancer Inst 1997;89:71-6.
9. Sanderson M, Shu XO, Jin F, et al. Weight at birth and adolescence and premenopausal breast cancer risk in a low-risk population. Br J Cancer 2002;86:84-8.
10. Titus-Ernstoff L, Egan KM, Newcomb PA, et al. Early life factors in relation to breast cancer risk in postmenopausal women. Cancer Epidemiol Biomarkers Prev 2002;11:207-10.
11. Ekbom A, Trichopoulos D, Adami HO, Hsieh CC, Lan SJ. Evidence of prenatal influences on breast cancer risk. Lancet 1992;340:1015-8.
12. Weiss HA, Potischman NA, Brinton LA, et al. Prenatal and perinatal risk factors for breast cancer in young women. Epidemiology 1997;8:181-7.
13. Potischman N, Troisi R. In-utero and early life exposures in relation to risk of breast cancer. Cancer Causes Control 1999;10:561-73.
14. Noller KL, Fish CR. Diethylstilbestrol usage: its interesting past, important present, and questionable future. Med Clin North Am 1974;58:739-810.
15. Smith OW, Smith GV. The influence of diethylstilbestrol on the progress and outcome of pregnancy as based on a comparison of treated with untreated primigravidas. Am J Obstet Gynecol 1949;58:994-1009.
16. Dieckmann WJ, Davis ME, Rynkiewicz SM, Pottinger RE. Does the administration of diethylstilbestrol during pregnancy have therapeutic value? Am J Obstet Gynecol 1953;66:1062-75.
17. Heinonen OP. Diethylstilbestrol in pregnancy. Frequency of exposure and usage patterns. Cancer 1973;31:573-7.
18. Herbst AL, Ulfelder H, Poskanzer DC. Adenocarcinoma of the vagina: association of maternal stilbestrol therapy with tumor appearance in young women. N Engl J Med 1971;284:878-81.
19. Colton T, Greenberg ER, Noller K, et al. Breast cancer in mothers prescribed diethylstilbestrol in pregnancy. J Am Med Assoc 1993;269:2096-100.
20. Greenberg ER, Barnes AB, Resseguie L, et al. Breast cancer in mothers given diethylstilbestrol in pregnancy. N Engl J Med 1984;311:1393-8.
21. Palmer JR, Hatch EE, Rosenberg CL, et al. Risk of breast cancer in women exposed to diethylstilbestrol in utero: preliminary results (United States). Cancer Causes Control 2002;13:753-8.
22. Labarthe D, Adam E, Noller KL, et al. Design and preliminary observations of the National Cooperative Diethylstilbestrol Adenosis (DESAD) Project. Obstet Gynecol 1978;51:453-8.
23. Bibbo M, Gill WB, Azizi F, et al. Follow-up study of male and female offspring of DES-exposed mothers. Obstet Gynecol 1977;49:1-8.
24. Hatch EE, Palmer JR, Titus-Ernstoff L, et al. Cancer risk in women exposed to diethylstilbestrol in utero. JAMA 1998;280:630-4.
25. Breslow NE, Day NE. Statistical Methods in Cancer Research, II: Design and Analysis of Cohort Studies. IARC Scientific Publication 88. Lyon: International Agency for Research on Cancer; 1987.
26. Surveillance, Epidemiology, and End Results (SEER) Program (http://www.seer.cancer.gov) SEER*Stat Database: Incidence-SEER 9 Regs Public Use, Nov 2003 Sub (1973-2001), National Cancer Institute, DCCPS, Surveillance Research Program, Cancer Statistics Branch, released April 2004, based on the November 2003 submission.
27. Mucci LA, Lagiou P, Tamini RM, Hsieh CC, Adami HO, Trichopoulos D. Pregnancy estriol, estradiol, progesterone and prolaction in relation to birth weight and other birth size variables (United States). Cancer Causes Control 2003;14:311-8.
28. Kaijser M, Granath F, Jacobsen G, Cnattingius S, Ekbom A. Maternal pregnancy estriol levels in relation to anamnestic and fetal anthropometric data. Epidemiology 2000;11:315-9.
29. Troisi R, Potischman N, Roberts J, et al. Associations of maternal and umbilical cord hormone concentrations with maternal, gestational and neonatal factors (United States). Cancer Causes Control 2003;14:347-55.
30. Duff GB, Brown JB. Urinary oestriol excretion in twin pregnancies. J Obstet Gynaecol 1974;81:695-700.
31. Trapp M, Kato K, Bohnet H-G, et al. Human placental lactogen and unconjugated estriol concentrations in twin pregnancies: monitoring of fetal development in intrauterine growth retardation and single intrauterine fetal death. Am J Obstet Gynecol 1986;155:1027-33.
32. Tamini R, Lagiou P, Vatten LJ, et al. Pregnancy hormones, pre-eclampsia, and implications for breast cancer risk in the offspring. Cancer Epidemiol Biomarkers Prev 2003;12:647-50.
33. Troisi R, Potischman N, Johnson CN, et al. Estrogen and androgen concentrations are not lower in the umbilical cord serum of pre-eclamptic pregnancies. Cancer Epidemiol Biomarkers Prev 2003;12:1268-70.
34. Troisi R, Potischman N, Roberts JM, et al. Maternal serum oestrogen and androgen concentrations in pre-eclamptic and uncomplicated pregnancies. Int J Epidemiol 2003;32:455-60.
35. Hovey RC, Asai-Sato M, Warri A, et al. Effects of neonatal exposure to diethylstilbestrol, tamoxifen, and toremifene on the BALB/c mouse mammary gland. Biol Reprod 2005;72:423-35.
36. Rothschild TC, Boylan ES, Calhoon RE, Vonderhaar BK. Transplacental effects of diethylstilbestrol on mammary development and tumorigenesis in female ACI rats. Cancer Res 1987;47:4508-16.
37. Rossouw JE, Anderson GL, Prentice RL, et al. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial. JAMA 2002;288:321-33.